Effect of Intravenous glutamine-dipeptide fortified enteral nutrition on clinical outcomes in patients after liver transplantation: A prospective randomized controlled study

Chinese Journal of Clinical Nutrition

Volumn 15, Issue 1, 2007, Pages 21-25

  Jiang, Hua ^a   Li, Bo ^a   Yan, Lv Nan ^a   Lu, Shi Chun ^a   Wen, Tian Fu ^a   Zhao, Ji Chun ^a   Wan, Wen Tao ^a   Jiang, Zhu Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Enteral nutrition; Glutamine dipeptide; Liver transplantation

Indexed keywords

GLUTAMINE DERIVATIVE; GLUTAMINE DIPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENTERIC FEEDING; FEMALE; HOSPITAL COST; HUMAN; INFORMED CONSENT; INTRAVENOUS FEEDING; LENGTH OF STAY; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL PATIENT;

EID: 34047260709     PISSN: 1674635X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Willis C, Maddrey E, Schiff R, et al. Transplantation of the liver [M]. 3rd ed. New York: Lippincott Williams & Wilkins, 2001.
2. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4 000 consecutive patients at a single center [J]. Ann Surg, 2000, 232(4):490-500.
3. DiCecco SR, Wieners EJ, Wieners RH, et al. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation [J]. Mayo Clin Proc, 1989, 64(1):95-102.
4. Patton KM, Aranda-Michel J. Nutritional aspects in liver disease and liver transplantation [J]. Nutr Clin Prac, 2002, 17(3):332-340.
5. Such J, Frances R, Munoz C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites [J]. Hepatology, 2002, 36(1):135-141.
6. Wicks C, Somasundaram S, Bjarnason I, et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation [J]. Lancet, 1994, 344 (8926): 837-840.
7. Hasse JM, Blue LS, Liepa GU, et al. Early enteral nutrition support in patients undergoing liver transplantation [J]. JPEN, 1995, 19(6):437-443.
8. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence [J]. Crit Care Med, 2002, 30(12):2022-2029.
9. Chinese source.
10. Jiang ZM, Jiang H, Furst P. The impact of glutamine dipeptides on outcome of surgical patients: systematic review of randomized controlled trials from Europe and Asia [J]. Clin Nutr, 2004, 23(suppl):17-23.
11. Furst P. [J]. 2005, 13(2): 67-69.
12. Tsoulfas G, Takahashi Y, Ganster RW. Activation of the lipopolysaccharides signaling pathway in hepatic transplantation preservation injury [J]. Transplantation, 2002, 74 (1):7-13.
13. Yokoyama I, Gavaler JS, Starzl TE. Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week [J]. Hepatogastroenterology, 1995, 42(2):205-208
14. Fish J, Sporay G, Beyer K, et al. A prospective randomized study of glutamine-enriched parenteral compared with enteral feeding in postoperative patients [J]. Am J Clin Nutr, 1997, 65(8):977-983.
15. Zhou Y, Jiang Z, Sun Y. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial [J]. JPEN, 2003, 27(3):241-245.
16. Furst P, Pogan K, Stehle P. Glutamine dipeptides in clinical nutrition [J]. Nutrition, 1997, 13(7-8):731-737.
17. Kudsk KA, Wu Y, Fukatsu K, et al. Glutamine-enriched total parenteral nutrition maintains intestinal interleukin-4 and mucosal immunoglobulin A levels [J]. JPEN, 2000, 24(3):270-275.
18. Chinese source.
19. Chinese source.